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Abstract
During particle therapy irradiation, positron emitters with half-lives ranging
from 2 to 20 min are generated from nuclear processes. The half-lives are such
that it is possible either to detect the positron signal in the treatment room
using an in-beam positron emission tomography (PET) system, right after the
irradiation, or to quickly transfer the patient to a close PET/CT scanner. Since
the activity distribution is spatially correlated with the dose, it is possible to use
PET imaging as an indirect method to assure the quality of the dose delivery. In
this work, we present a new dedicated PET system able to operate in-beam. The
PET apparatus consists in two 10 cm × 10 cm detector heads. Each detector
is composed of four scintillating matrices of 23 × 23 LYSO crystals. The
Content from this work may be used under the terms of the Creative Commons Attribution 3.0
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crystal size is 1.9 mm×1.9 mm×16 mm. Each scintillation matrix is read out
independently with a modularized acquisition system. The distance between
the two opposing detector heads was set to 20 cm. The system has very low
dead time per detector area and a 3 ns coincidence window, which is capable
to sustain high single count rates and to keep the random counts relatively
low. This allows a new full-beam monitoring modality that includes data
acquisition also while the beam is on. The PET system was tested during
the irradiation at the CATANA (INFN, Catania, Italy) cyclotron-based proton
therapy facility. Four acquisitions with different doses and dose rates were
analysed. In all cases the random to total coincidences ratio was equal or less
than 25%. For each measurement we estimated the accuracy and precision of
the activity range on a set of voxel lines within an irradiated PMMA phantom.
Results show that the inclusion of data acquired during the irradiation, referred
to as beam-on data, improves both the precision and accuracy of the range
measurement with respect to data acquired only after irradiation. Beam-on data
alone are enough to give precisions better than 1 mm when at least 5 Gy are
delivered.
1. Introduction
Dose range in proton therapy is subject to several sources of uncertainty, including the
incompleteness of physical models (Pia et al 2010) and the effects of registration and patient
movement (Hui et al 2008). These uncertainties worsen the already limited capabilities in
predicting relative biological effectiveness for all tissues, especially those close to the Bragg
peak. As a result, the use of beam angles that would place the distal edge close to critical
structures is discouraged (Grassberger et al 2011). This partially neutralizes the advantage of
charged particles with respect to photons.
One of the main actions that are being taken in order to overcome these problems is to
research effective methods for in vivo verification of the beam delivery and, in particular, of the
proton range in the patient. Since the sum of range uncertainties typically exceeds 2 mm, except
in some cases, such as lung or deep-seated treatments, where it might be bigger (Paganetti
2012), an in vivo range verification tool has to provide both millimetric accuracy and precision
in order to effectively contribute to the clinical practice. If effective, an in vivo monitoring
would allow better treatment planning by assuring the detection of discrepancies between the
planned and the actual delivery close to critical organs. Also, it could support experimental
activities for better understanding uncertainties and their sources, thus contributing to increase
the reliability of safety margins and eventually to enhance the number and diversity of beam
directions.
The most used in vivo range verification method is positron emission tomography (PET)
(Enghardt et al 2004, Knopf et al 2009, 2011). PET monitoring is based on the fact that during
proton therapy several positron emitters are generated in the irradiated region (Bennett et al
1978, Litzenberg et al 1992). These emitters, e.g., 11C, 13N and 15O, have half-lives that allow
to examine the subject during and after the irradiation with a PET scan (Parodi et al 2002).
The resulting images can then be used to measure indirectly the delivered dose (Del Guerra
et al 1997, Parodi and Enghardt 2000). Another similar method exists, where the detected
radiation comes from prompt gamma emission after nuclear excitation by the protons in tissue
(Polf et al 2009a, 2009b). Prompt gamma detection has the main advantage of a more direct
correlation between the photon signal and the dose range with respect to PET. However, it still
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suffers from low detector efficiencies, thus leaving PET as the only practical method at this
time (Moteabbed et al 2011).
The PET signal results from inelastic nuclear reactions with energy thresholds ranging
from 3 to 20 MeV. Therefore the distal activity fall-off is correlated, but not directly matched
to the dose distribution. Thus, there is much interest in determining how the β+ activation
can be used to estimate the dose distribution (Oelfke et al 1996, Parodi and Bortfeld 2006,
Attanasi et al 2008a, Grogg et al 2013, Knopf and Lomax 2013).
The established method is to use a Monte Carlo-simulated distribution of the positron
emitters and compare the predicted image with the measured image (Parodi et al 2007a,
Paganetti et al 2008). Other methods use analytical forward or back-filters that transform the
axial dose profile into the activity profile (Parodi and Bortfeld 2006) and vice versa (Attanasi
et al 2008a, 2011). A successful estimation of the dose range from the activity depends on the
accuracy of underlying cross section data (Espan˜a et al 2011) and requires in any case PET
images of excellent quality (Remmele et al 2011, Aiello et al 2013). However, achieving high
image quality is not always possible. PET imaging for proton therapy is subject to geometrical
and temporal constraints that are absent in clinical PET applications (Crespo et al 2006, Nishio
et al 2010). For systems placed around the immobilized patient in the beam line, i.e., in-beam,
the angular coverage is limited by the free passage needed for the beam port. Conversely, full-
ring systems need to be placed out of the beam line, thus requiring a mechanical movement
between the irradiation and the monitoring. This reintroduces registration uncertainties, partial
waste of the emitted radiation and worsens the effects of biological washout.
A systematic comparison of these modalities shows that off-beam monitoring is not
recommended, except for some specific tumours or unless the PET system is placed in the
same treatment room (i.e., in-room) (Shakirin et al 2011).
In-beam monitoring is the first clinical implementation of PET for monitoring of
radiotherapy. It was launched in 1997 at the experimental carbon ion therapy facility at GSI
Helmholtzzentrum fu¨r Schwerionenforschung (centre for heavy ions research), Darmstadt,
Germany (Enghardt et al 2004). The PET installation is completely integrated into the therapy
facility and has the potential to provide the best quality feedback for treatment monitoring,
since it requires no additional time to move the patient to the PET scanner. The ability to detect
alignment errors is lower than in other modalities. However, the artefacts due to incomplete
angular coverage can be mitigated, at least with respect to the beam direction, by increasing the
detectors size and reducing the gaps between the two heads (Crespo et al 2006). Additionally,
counting statistics can be improved if the acquisition is performed also during the dose delivery.
The main technological problem consists in filtering out data acquired during particles
extraction, because the strong beam-induced background noise floods the PET detectors
(Enghardt et al 2004, Parodi et al 2005, Crespo et al 2005). Such noise might originate
from the decay of β+-emitters with half-lives in the millisecond range (e.g., 8B, 9C and 12N)
with correspondingly high β+-endpoint energies, positron generating processes accompanying
nuclear reactions and random coincidences with the γ -decay of excited nuclear levels (Pawelke
et al 1997). Therefore, the effect is either a broadening of the β+ activity spatial distribution
or a paralysis of the acquisition system due to excessive random coincidence data that do not
carry any information regarding the β+ distribution (Enghardt et al 1999, Parodi et al 2002).
Thus, state of the art in-beam PET solutions are only applicable to synchrotron-based facilities
and their effectiveness is limited by the accelerator duty cycle (Nishikido et al 2010, Tashima
et al 2012, Nishio et al 2010, Shakirin et al 2011).
Based on previous experiences with the first dedicated in-beam DoPET system (Vecchio
et al 2009), we developed a new in-beam PET, with wider detectors and modularized
acquisition for better counting performances (Sportelli et al 2011a). In the following we
45
Phys. Med. Biol. 59 (2014) 43 G Sportelli et al
present the first reconstructed PET images of the activity produced during the continuous
irradiation of a polymethyl methacrylate (PMMA) phantom at the CATANA cyclotron-based
proton therapy facility. The new architecture and the improved dead time at the front-end
(Belcari et al 2007) allowed to mitigate the effects of random coincidence rates and to
acquire valid PET data in the high noisy environment produced by the irradiation (Sportelli
et al 2012).
The paper is organized as follows: in section 2, the distribution of PET activity in time
is described to give an idea of the trade-off between acquisition duration and available
statistics. The PET system, the experimental set-up and the software algorithms used for
image reconstruction and range determination are described in section 3. Section 4 reports the
obtained results: counting statistics, energy spectra, in-beam images and activity ranges. In
section 5 we discuss and conclude the work.
2. PET activity and range verification quality
Positron emitters production rate during irradiation is proportional to the current of the
accelerator, i.e., to the treatment dose rate. The production of radioisotopes competes with
the decay process. For most of the observed radioisotopes the irradiation condition is far
from the secular equilibrium and the result is a continuous increase on the β+ activity.
After the irradiation, the β+ decay is the only process occurring and the expected behaviour
of the activity over time is a sum of exponential decays which is the convolution of the
contribution of the various isotopes present in different quantities and decaying at different
speeds.
We are interested in quantifying the amount of statistics available from most abundant
isotopes produced by a continuous irradiation (beam-on) as compared to those available after
the end of it (beam-off). To do so we assume that the PET detectors have sufficiently low dead
time, in order not to paralyze during the irradiation because of the high background noise. In
this kind of comparison, the proportion between beam-on and beam-off data is independent
from the dose rate, i.e., it only depends on the half-life of each produced isotope and the
involved time intervals. For simplicity let us consider two main isotopes produced by protons
on PMMA, i.e., 15O and 11C, in a likely scenario in which the irradiation lasts 3 min and the
acquisition 10 min. Assuming that the production is a constant process, we can describe these
behaviours in arbitrary units for each separated isotope. To give an idea of the proportions
between beam-on and beam-off available data, we report in figure 1 (left) the activity rates
calculated as the result of the production–decay processes, with the corresponding integral
contribution of data acquired during and after the irradiation (right).
Since one of the main limiting factors in state of the art PET for in vivo monitoring is
the low statistics, we aim at demonstrating that in-beam data, taken while the beam is on, can
effectively contribute to improve the statistical accuracy of the reconstructed image.
In the following discussion we use three dataset types: we refer to the data acquired
during the irradiation as ‘beam-on’ data; all the remaining data is referred to as ‘beam-off’
data. We call ‘full-beam’ data the union of both datasets for a given acquisition. In order
to characterize the trade-off between acquisition duration and reconstruction noise, beam-off
data are reconstructed at 60, 180, 300 or 600 s after the end of the irradiation. To evaluate the
impact of beam-on data in range verification, we will compare the activity ranges calculated on
the reconstructed images and their statistical precision for a given monoenergetic irradiation
and for each dataset.
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(a) (b)
(c) (d)
Figure 1. Expected activity rates for 15O (a) and 11C (c). Integral of the activities over
time for 15O (b) and 11C (d). In (b) and (d) the grey line is the annihilation integrated
activity over time for beam-on only acquisitions, the black line is the integrated activity
that can be acquired after the beam shut down.
3. Materials and methods
3.1. The PET system
A planar positron imaging system was arranged at the beam line at CATANA proton therapy
facility (INFN, Catania, Italy) (Cirrone et al 2004) as in previous experiments (Attanasi et al
2008b). In comparison to the previous system (Vecchio et al 2009), the two detector heads were
increased four-fold, i.e., from 5 cm × 5 cm to 10 cm × 10 cm (Rosso et al 2013). The number
of detector modules per detector head was increased from 1 to 4. The gap between each module
is 6 mm. Each module is composed of 23 × 23 LYSO crystals of 1.9 mm × 1.9 mm × 16 mm.
The energy response of the used LYSO crystals is characterized by a high-energy tail due to
optical effects (Bonifacio et al 2010). The PET system was installed on the patient chair and
the centre of its detection area was aligned with the isocentre of the beam line in the treatment
room (Sportelli et al 2012, Rosso et al 2013). The distance between the two opposing detector
heads is adjustable from 7 to 30 cm. The field of view (FOV) is 10 cm×10 cm×D cm, where
D is the distance between the two detector heads. The point source resolution at the centre is
1.2 mm × 1.2 mm × 6.0 mm full width at half maximum.
The acquisition system features a custom modular board able to handle up to 18 modules
(Sportelli et al 2011a). Coincidence detection is performed by a synchronous processor
operating at 240 MHz and providing a coincidence resolution of 3 ns (Sportelli et al 2011b).
The maximum data collection rate for detected coincidences is about 1 million counts per
second (cps), though this limit has been never reached with eight modules, because of the
counting limits of single photons at the front-end.
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Table 1. Acquisitions performed at the CATANA facility.
Acquisition Total dose (Gy) Delivery time (s) Dose rate (Gy min−1)
1 2 170 0.7
2 5 186 1.6
3 10 197 3.0
4 20 124 9.7
The information of the on–off time points of beam irradiation is currently inferred from
the count rates and double checked with the beam monitors with a resolution of 1 s. For future
acquisitions it is planned to record the beam status from an external signal synchronized with
the accelerator.
The detection efficiency was calibrated by using a 11 cm × 11 cm × 0.3 cm planar plastic
container filled with 18F-fluorodeoxyglucose (FDG) placed at the middle of the FOV and
parallel to the detectors surface. The calibration is used for a correction of the imaging
uniformity and the detection sensitivity. The maximum coincidence counting rate observed
with the planar source filled with 26 MBq of FDG is 300 kcps.
3.2. Experimental set-up
Eye melanoma treatments at CATANA use typically 62 MeV proton beams with dose rates
that vary from 10 to 20 Gy min−1 (Cuttone et al 2011). Our measurements were performed
with monoenergetic passively collimated proton beams of 62 MeV. Only pristine Bragg peaks
were used, which are characterized by a peak-to-plateau ratio of 5. We did not apply any range
modulation in order to simplify the analysis at the activity distal endpoint. This differs from the
clinical practice, where a spread out Bragg peak (SOBP) obtained with a PMMA modulator
wheel is generally used to cover the whole extension of the tumour in depth with the prescribed
dose. In our experiment variable accelerator currents were delivered on the PMMA phantom
with dose rates at the low end of the typical values, i.e., ranging from 0.7 to 9.7 Gy min−1. A
homogeneous PMMA block phantom was placed at the centre of the FOV and irradiated with
a beam of 34 mm diameter. The distance between the two heads was set at 20 cm. A list of the
four performed irradiations is reported in table 1. The value of the absolute dose corresponds
to the dose at the entrance of the phantom.
Each measurement was performed sequentially on initially inactive phantoms of PMMA.
The dose and the beam current were preset at the beginning of the irradiation. The phantom
was irradiated continuously until reaching the preset dose in the beam monitor. The dose rate
was calculated as the total dose divided by the irradiation time. Activity position and intensity
were measured during the irradiation plus 600 s immediately after the end of the irradiation.
Coincidence data were stored in a list mode format. Single, coincident and random counts
rates were recorded in a separate file with binning intervals of one second. Random coincidence
rates were measured, but their spatial distribution was not acquired.
3.3. Image reconstruction
Images were reconstructed using an iterative Maximum Likelihood Expectation Maximization
(MLEM) reconstruction algorithm. The implemented algorithm makes use of a system model
computed using a multi-ray variant of the Siddon algorithm (Moehrs et al 2008). Images
and profiles used in this work were all obtained by performing five MLEM iterations. Each
iteration took 5 s to be computed on a 64 bit Intel i5-2400 based machine with four cores
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(a) (b)
Figure 2. Example of range determination on voxel line profiles for two images with
relatively low (a) and high (b) statistics. The lines marked in grey are the detected
proximal and distal edges of each line profile, whose endpoints are circled in black.
Horizontal dashed lines are the local threshold levels, while vertical ones are the detected
edge positions used for range determination.
running at 3.1 GHz. There are also plans for performing the same reconstruction on a GPU-
based implementation (Sportelli et al 2013). Data were reconstructed using a LOR based data
structure and applying a 350–850 keV energy window. The size of the reconstructed image is
100 × 100 × 100 voxels, 1 mm × 1 mm × 1 mm each, thus including the complete FOV up to
5 cm from the detectors surface. At present, no random or attenuation correction was applied.
3.4. Estimation of the activity distal fall-off
Several methods have been used for the estimation of the activity distal fall-off. The depth in
the phantom where the distal fall-off of the activity profile occurs can be measured by finding,
in the axial profile of the reconstructed activity distribution, the coordinate of the point where
the activity falls at 20% or 50% of the maximum value reached along the beam path (Parodi and
Bortfeld 2006, Parodi et al 2007b, Moteabbed et al 2011, Min et al 2013). A way to evaluate
the precision of this estimation is to repeat this measurement for each 1 mm2 thin profile along
the beam direction drawn in a defined region of interest (ROI) within the activated region. For
irradiations along the axial direction of the scanner, the profiles are naturally defined by lines
of voxels in the image space (Helmbrecht et al 2012, Min et al 2013, Surti et al 2011).
A problem in estimating the activity distal range on voxels lines is that such lines have
much lower statistics with respect to macroscopic profiles over larger regions. The low statistics
can cause spikes that make it difficult to properly determine the threshold level. Our approach
has been to first detect the proximal and distal edges of each line as the two longest monotonic
paths in the profile. In doing so, any relatively small spike with respect to the detected path
was removed (figure 2). The position of each edge was then determined as the threshold level
over the local path maximum. The proper choice of the range verification position in the
fall-off region in the clinical practice can be controversial, because ranges obtained with high
thresholds are affected by the width of the SOBP while those obtained with low thresholds are
generally more sensitive to image noise and to the beam energy spread (Parodi et al 2007a).
Thus, thresholds ranging from 20% to 50% are generally used (Knopf et al 2008). For our
purposes a 50% threshold value is a reliable choice because in this study we have do not
use SOBP. Also, lower thresholds would be more problematic due to the low statistics of the
datasets involved in this study.
For irradiations performed with monoenergetic beams, like in the present set-up, one can
suppose that the proton range is the same for each profile and then a constant depth for the
distal activity fall-off can be expected. Thus, the precision of the range measurement was
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(a) (b)
(c) (d)
Figure 3. Activity rates recorded during the four examined acquisitions. Vertical dashed
lines mark the end of each irradiation. Solid lines represent the total coincidence rates,
dot–dashed lines represent the randoms rates.
estimated by calculating the standard deviation of the measurements performed in each profile
(σdepth). The accuracy of the measurement of the distal fall-off of the activity profile can be
estimated as the deviation of the average depth (μdepth,t), as calculated from all the 1D profile
measurements with data acquired up to a time t, from the estimation of the average depth,
calculated in the same way, but using the whole statistics of 10 min of PET measurement with
beam-off (μdepth,600s). The latter is considered here as the best estimation, for each irradiation,
of the depth of the activity distal fall-off, being the measurement with the lesser statistical error.
4. Results
4.1. Comparison of counting statistics
Total and random coincidence rates for the four acquisitions are shown in figure 3. During the
irradiation the count rates for both true and random coincidences increase abruptly, indicating
the presence of fast nuclear processes. The random to total coincidence ratio decreases during
the irradiation. The maximum observed random to total coincidence ratio is 24.5%, at the
beginning of the 9.7 Gy min−1 irradiation. The acquisition rates at the beginning, at the end
and right after the irradiation are reported in table 2.
4.2. Energy distribution of the acquired data
Energy histograms of the acquired coincidences are reported in figure 4. The black
line corresponds to the coincidences acquired during the irradiation (beam-on). The grey
line corresponds to the coincidences acquired after it (beam-off). Dashed lines mark the
350–850 keV energy window used for image reconstruction. The spectrum of beam-off data
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Figure 4. Energy histograms for beam-on and beam-off data related to the four examined
acquisitions.
Table 2. Total (T) and random (R) coincidence rates for the four acquisitions at the
beginning, at the end and right after the irradiation.
Irradiation begin Irradiation end After irradiation
# T R R/T(%) T R R/T(%) T R R/T(%)
1 1.3 kHz 82 Hz 6.6 2.9 kHz 98 Hz 3.4 1.9 kHz 24 Hz 1.3
2 2.4 kHz 221 Hz 9.0 6.7 kHz 318 Hz 4.7 4.4 kHz 42 Hz 1.0
3 5.4 kHz 0.7 kHz 12.2 12.8 kHz 1.0 kHz 7.4 8.5 kHz 89 Hz 1.0
4 17.0 kHz 4.1 kHz 24.5 35.8 kHz 6.2 kHz 17.4 19.1 kHz 261 Hz 1.4
remains almost unchanged with the different dose rates, except for the 307 keV intrinsic
emission peak of 176Lu, which is more evident at low dose rates, as expected. A high-energy tail
is present in both beam-off and beam-on data due to optical attenuation in the used scintillating
crystals (Bonifacio et al 2010). This tail goes from the 511 keV peak to roughly 1 MeV. With
higher dose rates, beam-on data show an increasing degradation of the annihilation photo-peak
and a generally higher base level at all energies. This behaviour was also expected due to the
radiation noise during the delivery. The fraction of events within the selected energy window
is reported in table 3. While the beam is on, the fraction of events with energies >850 keV is
much higher and is increasing with the dose rate.
4.3. Distal fall-off during and after the irradiation
The reconstructed images for acquisition 1 (2 Gy) and 4 (20 Gy) are shown in figures 5 and 6,
respectively, including beam-on only data (a), 60 s of beam-off data (b), 60 s of full-beam data
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Table 3. Percentage of events within and at the two sides of the 350–850 keV energy
window used for image reconstructions. The sum of percentages may not be 100% due
to rounding errors.
Beam-off Beam-on
< 350 keV 350–850 keV > 850 keV < 350 keV 350–850 keV > 850 keV
1 29.1% 68.8% 2.1% 27.8% 61.9% 10.3%
2 25.6% 72.3% 2.1% 25.2% 63.7% 11.1%
3 23.4% 74.5% 2.0% 25.6% 62.2% 12.2%
4 22.4% 75.7% 1.9% 26.0% 54.6% 19.3%
Table 4. Mean values for the range profiles of the four examined acquisitions. Standard
deviations are reported within parentheses. Beam-on only column includes all data from
the beginning to the end of the irradiation (EOI). All values are expressed in mm.
Beam-on only Beam-off only Full-beam
# EOI 60 s 180 s 300 s 600 s 60 s 180 s 300 s 600 s
1 18.7 (2.2) 17.5 (3.0) 18.5 (1,3) 18.8 (1.0) 18.9 (0.9) 18.9 (1.5) 18.9 (0.9) 19.0 (0.8) 19.1 (0.7)
2 19.3 (0.8) 18.6 (1.4) 19.0 (0.5) 19.0 (0.5) 19.1 (0.5) 19.3 (0.6) 19.2 (0.5) 19.3 (0.5) 19.2 (0.5)
3 19.2 (0.6) 18.9 (0.7) 19.0 (0.5) 19.0 (0.4) 19.1 (0.4) 19.2 (0.5) 19.2 (0.4) 19.1 (0.4) 19.1 (0.4)
4 19.9 (0.6) 19.0 (0.5) 19.2 (0.3) 19.2 (0.3) 19.3 (0.2) 19.5 (0.4) 19.5 (0.3) 19.4 (0.3) 19.5 (0.2)
(c) and 600 s of full-beam data (d). The ROIs used for range determination are marked with a
dashed line. The ROIs are cylindrical with 2 cm diameter and 9 cm height. Profiles calculated
on such images are shown in figure 7(a)–(d), i.e., 2 Gy, and compared with images of the
fourth acquisition (e)–(h), i.e., 20 Gy. The dose range is reported as a black dashed line in
each plot. Dose range has been calculated given the depth of the Bragg peak in homogeneous
PMMA, i.e., 29 mm (Oelfke et al 1996), starting from the activity rising edge. In figure 7 it
can be seen how the image background noise is higher when the reconstruction is performed
with low statistics, i.e., low dose (a)–(d), rather than with high dose rates (e)–(h).
The noise level in the image is reflected in the distribution of the calculated distal ranges.
figure 8 shows the variation of the average depth and the relative standard deviation of the
measurement of the distal fall-off related to the activity profile for each of the four acquisitions
here considered. For each acquisition μdepth and σdepth are reported as estimated from beam-on
data only (t = 0, dotted line), beam-off data only (at t = 60 s, t = 180 s, t = 300 s and
t = 600 s), and full-beam data, including both beam-on and beam-off data. Values for μdepth,t
and σdepth,t are also reported in table 4. Plots show that the value of μdepth,t derived with
beam-off data only (grey line) is slightly underestimated with respect to the reference value
of μdepth,600s (highest statistics) when the acquisition time is short, while it converges to the
latter as the time increases. The μdepth,0s value (beam-on only) is overestimated with respect
to μdepth,600s in all cases but the 2 Gy irradiation. The inclusion of beam-on data (full-beam)
always improves the convergence speed. As for image noise, a higher standard deviation is
obtained for low doses and thus a less precise range is determined.
In each of the four acquisitions, the largest mean range deviation from the reference value
is seen in the images reconstructed with only 60 s of beam-off data. The same effect has been
observed in all the acquisitions with less than one million events (figure 9), thus suggesting a
systematic range determination error for very low statistics.
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(a)
(b)
(c)
(d)
Figure 5. Reconstructed images of the 2 Gy irradiation in three orthogonal planes,
centred in the field of view, for different time-sets: beam-on only data (a), first 60 s of
beam-off data (b), beam-on data plus 60 s of beam-off data (c), beam-on data plus 600 s
of beam-off data (d). The region marked with a dashed line represents the cylindrical
ROI used for range calculation. The diameter of the cylinder is 2 cm, the height is
9 cm.
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(a)
(b)
(c)
(d)
Figure 6. Reconstructed images of the 20 Gy irradiation in three orthogonal planes,
centred in the field of view, for different time-sets: beam-on only data (a), first 60 s of
beam-off data (b), beam-on data plus 60 s of beam-off data (c), beam-on data plus 600 s
of beam-off data (d). The region marked with a dashed line represents the cylindrical
ROI used for range calculation. The diameter of the cylinder is 2 cm, the height is
9 cm.
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(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
Figure 7. Profiles of the reconstructed images for 2 Gy (left column, (a)–(d)) and
20 Gy (right column, (e)–(h)) irradiations on different time-sets: beam-on only data
((a), (e)), first 60 s of beam-off data ((b), (f)), beam-on data plus 60 s of beam-off data
((c), (g)), beam-on data plus 600 s of beam-off data ((d), (h)). The plot is obtained by
superimposing the profiles of each voxel line included in the ROI (see figures 5 and 6).
The white dashed line is the mean of all voxel lines. The z coordinate of the dose range
is indicated with a black dashed line. Dose range has been calculated given the depth of
the Bragg peak in homogeneous PMMA, i.e., 29 mm, starting from the activity rising
edge.
5. Conclusions
We have built and optimized a modular dual-head PET system for treatment monitoring in
hadron therapy. The system can operate continuously in-beam and is able to successfully
acquire the produced β+ activity in a field-of-view of 10 cm × 10 cm × 10 cm also during
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Figure 8. Means and standard deviations of activity ranges versus time for all the
reconstructed images. The expected dose range of the used 62 MeV proton beams in
PMMA is 29 mm.
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Figure 9. Means and standard deviations of activity ranges versus total acquired events
for all the reconstructed images. The expected dose range of the used 62 MeV proton
beams in PMMA is 29 mm.
the irradiation. A distinction has been introduced between beam-on, beam-off and full-beam
data, referring to the acquisition output during the irradiation, after or both, respectively. The
question that has been addressed is if beam-on data can be used, either alone or jointly with
beam-off data, to improve the quality of the system response for monitoring purposes. A set
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of PET measurements was then performed at the cyclotron-based proton therapy facility at
CATANA, during the irradiation of a PMMA phantom at different dose rates and stopping the
acquisition 10 min after.
As already observed in other studies, a characteristic high random count rate appears
during the irradiation. This count rate is roughly constant with a continuous beam and increases
quickly with the dose rate. Since the phantom activation increases during the irradiation, the
randoms to total coincidences fraction decreases with time and becomes abruptly negligible
right after the beam turns off. The maximum observed fraction at the beginning of an irradiation
with 9.7 Gy min−1 dose rate is 24.5%. This value is of the same order of an acceptable
randoms fraction in clinical PET imaging. However, the noise structure is different from
random coincidence noise in conventional PET, thus future studies are expected to better
characterize its nature with respect to useful β+ activity and to improve the techniques used
for reconstructing such data.
The coincidence energy spectra of beam-on and beam-off data were also compared. A
small flat contamination from radiation with energies up to 2 MeV was observed in beam-on
data (2 MeV is the dynamic range of the system). With dose rates up to about 10 Gy min−1 no
significant degradation of the energy spectra was observed, being the percentage of acquired
events within the 350–850 keV energy window up to 62.2% of the total.
For each measurement and modality we estimated accuracy and precision by studying
the distribution of the activity ranges of a set of voxel lines within the activated material.
Results show that the inclusion of beam-on data improves both the precision and accuracy
of the proton range measurement with respect to data acquired after the irradiation only. The
use of beam-on data is enough to give a precision better that 1 mm (σ ) when at least 5 Gy
are delivered. Alternatively, beam-on data can be effectively used to increase the available
statistics for image reconstruction when the dose is lower. For the lowest available dose rate
(2 Gy min−1), beam-on data did not produce sub-millimetric range precision, but the precision
of the first 60 s of full-beam data is half with respect to that obtained with beam-off data
only.
The PET reconstructed signal is not quantitative. No developments were carried out to
study its capability as a quantitative instrument, but with proper calibration we expect its
response to be linear within a wide range of input rates. There are no reasons a priori that
would hamper its ability to give quantitative results more than in conventional PET systems.
The results of this investigation are promising for improving the quality and promptness
of PET monitoring, though there is still a big margin for improvement. The proposed in-beam
PET system has in principle the same geometrical limitations as previous in-beam solutions,
but uses new electronics that allow to reduce the acquisition duration. It is compatible with
Monte Carlo based simulations as well as with all the range verification techniques that have
been used so far. However, it requires the detectors response to be included in the simulation
model so as to take into account the artefacts due to the limited angular coverage. Washout
effects are expected to be less prominent than in any other PET imaging technique, since the
acquisition lasts only a few minutes from the beginning of the irradiation.
Future work is planned to increase the angular coverage of the system, in order to improve
random coincidences management, to refine system synchronization with the beam and to
characterize the detectors response. Extending the detectors area from 10 cm × 10 cm to
15 cm × 15 cm would require no major changes. The number of detector modules would
increase from 8 to 18 and the software analysis would be more complex, but the overall
acquisition architecture and implementation would remain the same.
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